Leading Analyst Case Study: Global Pharma Leader Gains Significant Process Improvements and ROI from Holistic Revenue Management

Share Article

Model N's Integrated Approach Reduces Regulatory and Financial Risk

With several global Top Ten selections in recent months, Model N has emerged as the acknowledged leader in delivering integrated, purpose-built Revenue Management solutions for drug and device manufacturers.

Model N, Inc., the leader in Revenue Management solutions, today announced that a recent Gartner case study of a leading pharmaceutical manufacturer deploying Model N gives high praise to the solution's holistic, integrated approach to managing core revenue life cycle processes.

The company highlighted in the case study needed to replace outdated legacy systems that were unable to fulfill evolving regulatory requirements in the U.S. and abroad. At the same time, the company required more robust capabilities to help it grow its managed care business, improve its analytics capabilities, better integrate with its legacy SAP ERP system, and reduce revenue leakage across its government and commercial lines of business.

The case study states that Model N was selected for its integrated platform, ease of use, data transparency, superior integration with SAP, and ability to partner with the customer and build a strong business case. According to the study, after the implementation went live in time and within budget, the customer has already realized:

  • $4M in savings alone from better pricing decisions on one key product
  • Enhanced chargebacks analytics capabilities that are yielding increasingly higher monetary returns
  • High user acceptance due to enhanced usability and functionality

In conclusion, the case study shows how the company replaced its outdated solutions with a transparent, integrated Revenue Management solution that delivers both peace of mind and significant ROI.

Read the full case study here.

Supporting Quotes

"The Life Science Revenue Management cycle is far too critical and complex to be left to spreadsheets or bootstrapped ERP modules," said Dale Hagemeyer, Research Vice President at Gartner. "The downside risk is too great and those who have gotten it right have actually achieved substantial ROI by taking an enterprise-wide approach. Life Science companies have mature options available to support all aspects revenue management plus strong analytics. Payback is often as less than a year so there is no reason to suffer through more revenue leakage or regulatory risk."

"This case study provides a roadmap for Life Science finance and IT leadership to prioritize their investment dollars in Revenue Management systems that are proven in large-scale, global deployments," said Sujay Jadhav, General Manager, Life Sciences, at Model N. "With several global Top Ten selections in recent months, Model N has emerged as the acknowledged leader in delivering integrated, purpose-built Revenue Management solutions for drug and device manufacturers."

Supporting Resources

Another Global Top Ten Life Sciences Leader Selects Model N
Model N Revenue Management for Life Sciences

About Model N

Model N is a leader in Revenue Management solutions, offering an integrated suite of applications for analytics, pricing strategy and execution, contracts, compliance, and settlements optimized for the industry practices of Life Sciences and High Tech companies.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Cassidy
Visit website